Summary: This study tries to define the incidence, survival, and risk factors of childhood cancer in Iran. A literature review on published articles was conducted by using different search engine from November 1974 to October 2008. The incidence rate of childhood cancer in Iran was 48 to 112 and 51 to 144 per million among girls and boys in multi geographical settings, respectively. The most common cancer in children from 0 to 14 years old were leukemia (incidence rate=8 to 62/million), lymphoma (3 to 23), and central nervous system tumors (3 to 22). The mortality rate of childhood cancers was 42 and 49 per million among girls and boys, respectively in 2004. A positive association between ABO blood groups, family history of cancer, drug usage during pregnancy, fathers' job, history of radiation, and parental smoking habit were found with childhood leukemia. It is essential that the effect of geographical differences on childhood cancer incidence rates and high mortality rate to be investigated in future studies.
C
ancer incidence is the third cause of death in Iran after coronary heart disease, accidents, and other natural phenomenon. 1 However, cancer is a rare disease among children <15 years old, compared with adults, presenting peculiar characteristics, so it should be analyzed separately. The incidence rate of childhood cancer is estimated by World Health Organization as about 100 per million children (all rates are presented per million). 2 Good quality population level statistics on the cancer incidence at young ages have been obtained much more difficult and serious than adults ones who were under reporting. This difficulty has been reported even in western countries too. 2 The population of Iran is about 70 million where 29% are children (http://www.sci.org.ir/portal/faces/public/ census 85). More than 11 ethnic groups are living in 30 provinces of Iran (Fig. 1) . These variations cause heterogeneity on cancer incidence in the country. The first cancer registry in Iran was a joint functional effort by Tehran University and ''International agency for research on cancer'' established in the Caspian Littoral to create reliable documents about the incidence of esophageal cancer in the north of Iran in 1968 3, 4 ( Fig. 1) . In 1976, Fars province cancer registry was ascertained and reported the number of cancer cases from 1982 to 1985. 5 The national cancer registry has been developed after the Iranian parliament passed a bill mandating the report of all cancer tissues to the Ministry of Health in 1984. This pathologic-based cancer registry covered 81% of cancer cases in 2006. The incidence of childhood cancer was reported about 60 per million. 6 In 1998, cancer research center of cancer institute has started to collect cancer data in Tehran Metropolis by a population-based method. This center reported an incidence of 144 for childhood cancer from 1998 to 2001. 7 The digestive disease research center established a population-based cancer registry in 5 provinces, a total population of about 9.5 million in Golestan, Ardebil, Kordestan, Kerman, and Khozestan provinces were covered in this registration. The first report on Ardebil data showed an incidence rate of 50 for childhood cancer from 1996 to 1999. 8 Ministry of Health operated a system to register the causes of deaths based on Iranian public cemeteries records in a sample of 24 cities from 1966. Finally this system covered the population of entire country of Iran in 1995 9 when a national regulation was approved for executing a comprehensive program to certificate all deaths by age, sex, cause, and place of residence. After running a piloted in Bushehr province in 1997, it has been developed and covered 29 provinces in 2004. 1 Hence, there are several sources to define the situation of childhood cancer in Iran. The aim of this review is to document the incidence, survival, and risk factors of cancer in Iranian children.
METHODS
We conducted a literature review on published articles from November 1974 to October 2008 to assess the incidence, survival, and risk factors of childhood cancer in Iran. Since the first report ofchildhood cancer was published in 1974, 10 this year was selected as starting point. The search strategy included all papers containing ''childhood cancer,'' ''childhood tumor,'' ''childhood malignancy,'' and ''childhood carcinoma'' that were combined with the word ''Iran'' in their titles and abstracts. Hindering efforts to gather all published articles, particularly those published in Persian medical journals were the fact that they did not have a citation index; most of them were searched by hand. Several authors were asked to provide us a copy of their published articles. Different search engines were used including: PubMed (http://www.ncbi.nlm.nih. gov/sites/entrez), SID (http://www.sid.ir/fa/index.asp), and IranMedex (http://www.iranmedex.ir ). Over 3000 issues of 103 Persian medical journals were assessed manually from the library of Medical Faculty of Tehran University, the reference medical library of Iran University, and the central library of Tabriz University. Unpublished data and abstracts were not included in this study.
RESULTS
There were 32 citations in Medline, 37 in IranMedex, and 48 in the SID databases. One hundred and seventeen full text articles on childhood cancer in Iran have been reviewed. Among them, 24 articles were published in Persian. Seven national reports, 10 provincial reports, and 1 dissertation on cancer registry in 5 provinces (1996 to 2000) have been reviewed too.
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Incidence
The incidence rate of Iranian childhood cancers was 48 to 112 and 51 to 144 among girls and boys, respectively (Table 1) . 6, 7, [13] [14] [15] [16] The highest incidence rate was reported in Tehran Metropolis. 7 The male to female ratio was 74% to 252% and the percent of childhood cancer was 1.1% to 3.4% of all types of cancers, respectively.
Leukemia
The incidence rate of leukemia was 12 to 62 and 9 to 24 among girls and boys, respectively. The highest incidence was reported among boys in Golestan province (62). 15 The incidence rate of acute lymphocytic leukemia (ALL) was 27 and 38 among girls and boys, respectively, in Fars province in 2001. 17 
Central Nervous Sysytem Tumors
The incidence rate of central nervous system (CNS) tumors was 3 to 22 and 4 to 21 among girls and boys, 6.5
*Age standardized Incidence rate (by world populations). wThe estimated children population in 9 provinces.
ASR indicates age standardized incidence rate; CNS, central nervous system.
respectively. CNS tumors were higher among boys in Tehran 18 and girls in Ardebil 19 than other provinces. 7, 12 The most common brain tumor was astrocytoma according to a retrospective study on 619 children who were admitted to a neurosurgic center in Tehran between 1978 and 2003. 20 
Lymphoma
The incidence rate of lymphoma was 3 to 23 and 3 to 9 among girls and boys, respectively. Highest rates were reported in national cancer registry. 12 A male to female ratio of 2.7 to 3.2, a prevalence of mixed cellularity subtype of 45% to 75%, and stages III and IV patients of 50% to 70% were reported. 19, 21, 22 Other Tumors
The incidence rate of thyroid cancer was 1.3 and 0.2 among girls and boys, respectively, from 1996 to 2000. 18 In a study on 55 case of Wilm tumor from 1992 to 2002 showed that 51% were stages III to V and favorable histologic finding was diagnosed in 54%. 23 
Survival
The mortality rate of childhood cancers was 42 and 49 among girls and boys, respectively ( Table 2 ). The percent of cancer mortality per all causes of child deaths was 0.1% in neonate, 3.1% in 1 to 59 months, 1.2% in <5-year-old, and 8.8% in 5 to 14 years old in 2004. The highest mortality rate was reported among children below 1 year of age (about 160). The burden of childhood cancer was estimated about 35,000 years. 1 During 1996 to 2002, the 5-year relative and overallsurvival rate for ALL were 65% and 90% in children below 5 years of age, respectively. 24 The complete remission rate of ALL was reported 79% and about 13% of patients who had a relapse. Second remission was achieved in 3% of relapsed cases in a study from 1997 to 2000. 25 Another study showed that the 5-years survival rate of 72 cases of ALL was 73%. 26 The mortality after induction remission chemotherapy was shown to be 30% in acute myelocytic leukemia. 27 The overall and disease-free survival rates of Hodgkin disease were reported to be 91% and 74%, respectively, over a follow-up period from 6 months to 17 years from 1972 to 1989. 21 Another study on Hodgkin disease showed an overall survival rate of 80% and a disease-free survival rates for stages I and II of 86% and stages III and IV of 73% by following up period from 6 months to 10 years. 22 The relative relapse-free and overall survival rates at 4 years for Wilm tumor were reported to be 71% and 86%, respectively. 23 The median survival rate of ovarian germ cell tumor in girls was reported to be 24 months. 28 
Risk Factors
A positive association between ABO blood groups, family history of cancer, drug usage during pregnancy, fathers' job, history of radiation, and parental smoking habit with childhood leukemia were reported. [29] [30] [31] Residence near a very high voltage overhead power lines, in distances 500 m and magnetic fields greater than 0.45 micro Teslas, was reported as a risk factor for leukemia. 32 A clustering childhood cancer in districts located in the inner city areas of Tehran, the older part of the city with higher population density, and environmental hazards were reported. 33 The prevalence of Epstein-Barr virus infection was 88% in Hodgkin disease. 34 Seasonal variation was demonstrated for ALL, Burkitt lymphoma, and acute myelocytic leukemia. 35 
DISCUSSION
This report presented childhood cancer incidence and mortality data in Iran for the period 1974 to 2008. The main limitation was the fact that there was no citation index for published articles in Persian medical journals. Thus, some articles might be missed in our review. Some data were not included in articles to allow for appropriate documentation; therefore we had to omit them.
According available data, the most common childhood cancer were leukemia, lymphoma, and CNS. For these types of cancers, and most others, the incidence rates among males were higher than females. The childhood cancer in Tehran (capital city) was higher than other provinces. The difference incidence rates between the provinces and the sex are surprised findings. Those differences might be due to different functions on the method of cancer registration, capturing data from referral hospitals, under reporting, or geographical and ethnic variations. The sex difference which appears maximum among ages 5 to 9 in Golestan province may be due to sex disparities on diagnosis and treatment in this province. However, such difference was also seen in other province and tumor sites are still remained unexplained.
Among the 4 countries (Cyprus, Egypt, Israel, and Jordan), the members of Middle East cancer consortium, the childhood cancer incidence rate in Tehran is more similar to the data of Jordan during the period 1996 to 2001, where childhood cancer was reported ranging from 98 to 179 and 137 to 161 in female and male, respectively. 37 The age standardized rates for all childhood cancers were reported to be 127 and 88 Indian boys and girls from 1990 to 2001, respectively. 38 Furthermore, the first report of Izmir cancer registry showed a rate of 125 among both sexes in 1994. 39 Our review shows that childhood cancer in Iran is significantly less than developed countries. 37, 40, 41 The differences on the incidence rate might be due to the method of cancer registration, environmental exposures, or genetic background.
The childhood cancer mortality rate 13 is more than other mortality reports (ie, surveillance, epidemiology, and end results with a rate of 24). The mortality among children below 1 year of age was 4 times more than other age group ( Table 2 ). The high reported mortality of childhood cancer in Iran may be due to the low education or least awareness of the parents, late diagnosis, or the low access to the effective treatment. 42 The survival rate of acute leukemia was relatively good in some regions in Iran compared with the developed countries. 43 This might be due to the high access to the effective treatment and trained staffs in those centers. 44 However, it is necessary to pay more attention to early diagnosis, screening, effective treatment, and palliation to increase the survival rate of childhood cancers in Iran. 45 The risk factors for childhood cancer are still unexplained. However, studies had speculated that some factors may have a role on the etiology (ie, specific environmental exposures, ABO blood groups, and Epstein-Barr virus infection). Therefore, more studies and investigation in future would be essential. Considering the population pyramid in Iran shows that the children population decreased from 44% in 1976 to 29% in 2006. The trend of childhood cancer was still unknown up to date as a contemporary backbone for any cancer control program among the nation of Iran.
The data from this study may be used as the baseline information to establish a population-based registry of childhood cancers in the country for health care and research purposes. However, more investigations are needed to develop effective strategies to control these disorders in high risk areas.
